Have an "Exit Plan" for Antipsychotics in Dementia Patients

Growing interest in Nuedexta (dextromethorphan/quinidine) will raise questions about how to treat agitation or psychosis in dementia patients.

About one in 6 nursing home residents take an antipsychotic.

But benefits are small at best. Plus, there's one more death for every 50 to 100 dementia patients on an atypical for 8 to 12 weeks.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote